Aaker, D. A. (1989). Managing assets and skills. The key to a sustainable competitive advantage. Calif Manage Rev, 31(2): 91–106. DOI:10.2307/41166561.
Amsden, A. H. & Mourshed, M. (1997). Scientific publications, patents and technological capabilities in late-industrializing countries. Technol Anal Strateg Manag; 9(3): 343–360. DOI:10.1080/09537329708524289.
Alliance for Regenerative Medicine (ARM), Available Products, accessed on 1 June 2021. https://alliancerm.org/available-products/.
Alliance for Regenerative Medicine (ARM). (2022). Regenerative Medicine: Disrupting the Status Quo. https://alliancerm.org/sector-report/2021-annual-report/.
Arojärvi, O. (2001). How to Value Biotechnology Firms: A Study of Current Approaches and Key Value Drivers. MS thesis, Aalto University, http://urn.fi/URN:NBN:fi:aalto-2020111714729.
Aslami, M. J. (2019). The effect of project management on organizational performance – the case of NGOs in Afghanistan. MBA Thesis, Istanbul Aydin University, DOI:10.2139/ssrn.3395721.
Barney, J. B. (1986). Organizational culture: Can it be a source of sustained competitive advantage? AMR; 11(3): 656–665. DOI:10.2307/258317.
Becker, G. S. (1964). Human capital: A theoretical and empirical analysis, with special reference to education. NBER. http://www.nber.org/chapters/c14407.
Bogue, D. J. (1969). Principles of Demography. New York: Wiley.
Chen, L. Y. (2017). Yearbook of Applied Biotechnology Industry. Taipei, DCB. 2017.
Chang, C. W.,Wu, C. R. & Lin, C. T. (2006). An application of AHP and sensitivity analysis for selecting the best slicing machine. Comput Ind Eng 2007; 52(2): 296–307. DOI:10.1016/j.cie.
Chang, P. L. & Chen, Y. C. (1994). A fuzzy multi-criteria decision making method for technology transfer strategy selection in biotechnology. Fuzzy Sets Syst; 63(2): 131–139. DOI:10.1016/0165-0114(94)90344-1.
Chen, Y. C., Cheng, H. F. & Yeh, M. K. (2017). Cell therapy regulation in Taiwan. Cell Transplant; 26(3): 483–492. DOI:10.3727/096368916X693293.
Chesnais, F. (1988). Technical cooperation agreements between firms. STI Review; 4(0): 51–120.
Crawford, L. (2006). Developing organizational project management capability: Theory and practice. Proj Manag J; 37(3): 74–86. DOI:10.1177/875697280603700308.
Dahlman C and Westphal L. The meaning of technological mastery in relation to transfer of technology. Ann Am Acad Political Soc Sci 1981; 458: 12–26. http://www.jstor.org/stable/1044311.
Edvinsson L and Sullivan P. Developing a model for managing intellectual capital. Eur Manag J 1996; 14(4): 356–364. DOI:10.1016/0263-2373(96)00022-9.
Ernst H. Patent information for strategic technology management. World Pat Inf 2003; 25(3): 233–242. DOI:10.1016/S0172-2190(03)00077-2.
Evans JS. Strategic flexibility for high technology manoeuvres: A conceptual framework. J Manag Stud 1991; 28(1) :69–89. DOI:10.1111/j.1467-6486.1991.tb00271.x.
Farrell B, Kenyon S and Shakur H. Managing clinical trials. Trials 2010; 11: 78. DOI:10.1186/1745-6215-11-78.
Fishman M and Porter J. A new grammar for drug discovery. Nature 2005; 437: 491–493. DOI:10.1038/437491a.
Fujiwara T. Real options analysis on strategic partnerships of biotechnological start-ups. Technol Anal Strateg Manag 2014; 26(6): 617–638. DOI: 10.1080/09537325.2014.923834.
Gabus A and Fontela E. The DEMATEL Observe. Geneva, Switzerland: Battelle Geneva Research Center. 1976.
Gabus A and Fontela E. World problems, an invitation to further thought within the framework of DEMATEL. Geneva, Switzerland: Battelle Geneva Research Center. 1972:1–8.
Grant RM. Toward a knowledge-based theory of the firm. Strat Mgmt J 1996; 17(S2): 109–122. DOI:10.1002/smj.4250171110.
Hofer CW and Schendel D. Strategy formulation: analytical concepts. Minnesota, West Publ., 1980.
Industrial Developmental Bureau, Ministry of Economic Affairs, Taiwan (R.O.C.). (2022). 2021 Taiwan Biotechnology Industry White Paper.
IQVIA. (2021). Global Medicine Spending and Usage Trends: Outlook to 2025. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-medicine-spending-and-usage-trends-outlook-to-2025.
IQVIA. (2021). The Global Use of Medicines 2022: Outlook to 2026. https://www.iqvia.com/insights/the-iqvia-institute/reports/the-global-use-of-medicines-2022.
IQVIA. (2022). Biosimilars to Continue Rapid Growth Over the Next Decade. https://www.iqvia.com/blogs/2021/12/biosimilars-to-continue-rapid-growth-over-the-next-decade.
Khalil TM. Management of technology: The key to competitiveness and wealth creation. Boston: McGraw-Hill. 2000.
Konstantinov I. E. In search of Alexander A. Maximow: the man behind the unitarian theory of hematopoiesis. Perspectives in biology and medicine 2000; 43(2); 269–276. https://doi.org/10.1353/pbm.2000.0006.
Laínez JM, Schaefer E and Reklaitis GV. Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry. Comput Chem Eng 2012; 47: 19–28. DOI: 10.1016/j.compchemeng.2012.07.002.
Levitt S and Snyder J. Political parties and the distribution of federal outlays. AJPS 1995; 39(4): 958–980. DOI:10.2307/2111665.
Luo SW. A Study of Successful and Failure Path for New Product Development. MS Thesis, Feng Chia University, 2010. https://hdl.handle.net/11296/32xmu5.
McCulloch E. A., Till J. E., Siminovitch L. The distribution of colony-forming cells among spleen colonies. Journal of cellular and comparative physiology 1963; 62; 327–336. https://doi.org/10.1002/jcp.1030620313.
Murdick RG. Business policy: a framework for analysis. Ohio, Grid Pub., 1980.
Niosi J and Bas TG. The competencies of regions – Canada's clusters in biotechnology. Small Bus Econ 2001; 17: 31–42. DOI:10.1023/A:1011114220694.
Porter ME. Competitive strategy: techniques for analyzing industries and competitors. New York: Free Press, 1980.
Porter ME. The Competitive Advantage of Nations. New York: Free Press. 1990.
Rautiainen T. Critical Success Factors in Biopharmaceutical Business: Finland vs. California. MS thesis, 2000.
Saaty TL and Vargas L. Decision making with the analytic network process. International Series in Operations Research & Management Science 2006; 95: 1–26. DOI:10.1007/0-387-33987-6.
Saaty TL. Decision making – the analytic hierarchy and network processes (AHP/ANP). J Syst Sci Syst Eng 2004; 13(1): 1–35. DOI:10.1007/s11518-006-0151-5.
Saaty TL. The analytic hierarchy process: planning, priority setting, resource allocation. New York: McGraw-Hill International Book Co., 1980.
Song, Jy., Kang, H.J., Ju, H.M. et al. Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses. Sci Rep 2019; 9; 6623. https://doi.org/10.1038/s41598-019-42964-7.
Sullivan P. Focus groups confirm that MDs, public differ on role of private health care. CMAJ 1996; 154(8): 1247–1249.
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA). Overview of R&D of Taiwan’s regenerative medicine industries (in Chinese). Taipei, TRPMA, 2020.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5); 861–872. https://doi.org/10.1016/j.cell.2007.11.019.
Takeuchi H and Nonaka I. The new product development game. Harv Bus Rev 1986; 64(1): 137–146.
Tamura H and Akazawa K. Structural modeling and systems analysis of uneasy factors for realizing safe, secure and reliable society. J Telecom Inf Technol 2005; nr 3: 64–72.
Tarek M. Khalil. Management of Technology: The Key to Competitiveness and Wealth Creation. New York: McGraw Hill. 2000.
Teece DJ. Firm organization, industrial structure, and technological innovation. J Econ Behav Organ 1996; 31(2): 193–224.
Thomas E. D. Bone marrow transplantation: a review. Seminars in hematology 1999; 36(4 Suppl 7); 95–103.
Till, J. E., & McCulloch, E. A. A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells. Radiation Research 1961; 14(2); 213–222. https://doi.org/10.2307/3570892.
Tsai TH, Ling TY and Lee CH. Adoption of regulations for cell therapy development: Linkage between Taiwan and Japan. Clin Transl Sci 2020; 13(6): 1045–1047. DOI:10.1111/cts.12813.
Tushman ML and Rosenkopf L. Organizational determinants of technological change: Towards a sociology of technological evolution. Res Organ Behav 1992; 14: 311–347.
Van Norman GA. Drugs, devices, and the FDA: part 1: an overview of approval processes for drugs. JACC: Basic to translational science 2016; 1(3): 170–179. DOI:10.1016/j.jacbts.2016.03.002.
Wernerfelt B. A resource-based view of the firm. Strat Mgmt J 1984; 5(2): 171–180. Retrieved August 26 2021, from www.jstor.org/stable/2486175.
Wood EH, Tang PH, De la Huerta I, et al. Stem cell therapies, gene-based therapies, optogenetics, and retinal prosthetics: current state and implications for the future. Retina 2019; 39(5): 820–835. DOI:10.1097/IAE.0000000000002449.
Zheng XD. The beneficial analysis of Taiwan's biotechnology industry. Journal of Bank of Tawian 2014; 60(3); 71-95. https://www.bot.com.tw/SiteCollectionDocuments/resource_103/quarterly_103/60_3/quarterly60_3_5.pdf